#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3705556	B	Inhibition Assay: Inhibition of human t-PA was determined by the method described in [0092]-[0098] using recombinant human tissue-type plasminogen activator (Actilyse®) from Boehringer Ingelheim at 290 U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at 4 mM, 2 mM, and 1 mM as substrate; results are reported as Ki values (nanomolar).	Homo sapiens	20	ALA3639037	single protein format	BindingDB Database
2.	ALA3705558	B	Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Stürzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).	Homo sapiens	22	ALA3639037	single protein format	BindingDB Database
3.	ALA3705559	B	Inhibition Assay: Inhibition of human FXIa was determined by the method described in [0092]-[0098] using activated human Factor XI from Enzyme Research Laboratories at 96 ng/mL and H-D-Lys(Cbo)-Pro-Arg-pNA (Pefachrome PCa) at 5 mM, 4 mM, and 2 mM as substrate; results are reported as Ki values (nanomolar).	Homo sapiens	22	ALA3639037	single protein format	BindingDB Database
4.	ALA3705560	B	Inhibition Assay: Inhibition of human aPC was determined by the method described in [0092]-[0098] using human activated protein C from Enzyme Research Laboratories at 2.2 nM and H-D-Lys(Cbo)-Pro-Arg-pNA (Pefachrome PCa) at 2 mM, 1 mM, and 0.5 mM as substrate; results are reported as Ki values (nanomolar).	Homo sapiens	22	ALA3639037	single protein format	BindingDB Database
5.	ALA3705561	B	Inhibition Assay: Inhibition of human C1s was determined by the method described in [0092]-[0098] using native human activated C1s complement component from Calbiochem at 29 nM and Val-Ser-Arg-pNA (S2314) at 8 mM, 6 mM, and 4 mM as substrate; results are reported as Ki values (nanomolar).	Homo sapiens	21	ALA3639037	single protein format	BindingDB Database
6.	ALA3705562	B	Inhibition Assay: Inhibition of human FXa was determined by the method described in [0092]-[0098] using activated human Factor X from Enzyme Research Laboratories at 5 mIU/mL and MeOCO-d-Cha-Gly-Arg-pNA (Pefachrome FXa) at 2 mM, 1 mM, and 0.5 mM as substrate; results are reported as Ki values (nanomolar).	Homo sapiens	22	ALA3639037	single protein format	BindingDB Database
7.	ALA3705563	B	Inhibition Assay: Inhibition of human C1r was determined by the method described in [0092]-[0098] using native human activated C1r complement component from Calbiochem at 100 nM and Val-Ser-Arg-pNA (S2314) at 16 mM, 12 mM, and 8 mM as substrate; results are reported as Ki values (nanomolar).	Homo sapiens	19	ALA3639037	single protein format	BindingDB Database
8.	ALA3705624	B	Inhibition Assay: Inhibition of human FIIa was determined by the method described in [0092]-[0098] using human alpha-thrombin from Enzyme Research Laboratories at 0.1 NIH U/mL and Mes-d-Cha-Gly-Arg-pNA (Pefachrome tPA) at 2 mM, 1 mM, and 0.5 mM as substrate; results are reported as Ki values (nanomolar).	Homo sapiens	21	ALA3639037	single protein format	BindingDB Database
9.	ALA3707860	B	Inhibition Assay: The inhibitory effect for the individual enzymes was determined in analogy to a previously disclosed method (Stürzebecher et al., J. Med. Chem., 40, 3091-3099 (1997)).	Homo sapiens	22	ALA3639037	single protein format	BindingDB Database
10.	ALA4356344	B	Inhibition of human plasmin using tosyl-Gly-Pro-Lys-pNA as substrate	Homo sapiens	3	ALA4354815	single protein format	Scientific Literature
11.	ALA4356345	B	Inhibition of human plasma kallikrein using S2302 as substrate	Homo sapiens	3	ALA4354815	single protein format	Scientific Literature